Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study. - Stella F; Chiappella A; Magni M; Bonifazi F; De Philippis C; Musso M; Cutini I; Ljevar S; Barbui AM; Farina M; Martino M; Massaia M; et al. (British journal of haematology, 2025)